{
    "2018-02-22": [
        [
            {
                "time": "",
                "original_text": "处方外流，上药、国大、一心堂加速切割院外DPT市场",
                "features": {
                    "keywords": [
                        "处方外流",
                        "上药",
                        "国大",
                        "一心堂",
                        "DPT市场"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "这900亿市场，医药巨头争夺战一触即发！",
                "features": {
                    "keywords": [
                        "900亿市场",
                        "医药巨头",
                        "争夺战"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物：建议配置超跌质优公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "超跌",
                        "质优公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "本周解禁市值981亿元 为年内偏高水平",
                "features": {
                    "keywords": [
                        "解禁市值",
                        "981亿元",
                        "年内偏高水平"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}